Company profile for Refnot-Pharm

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Refnot-Pharm, LLC, founded in 2006 and based in Russia, specializes in the development and production of genetically engineered cytokine-based drugs. The company focuses on innovative TNF (Tumor Necrosis Factor)-based therapies. While early systemic TNF therapies showed high toxicity, later breakthroughs came from combining TNF with melphalan and IFN-gamma via isolated regional perfusion, yielding strong results in limb sarcom...
Refnot-Pharm, LLC, founded in 2006 and based in Russia, specializes in the development and production of genetically engineered cytokine-based drugs. The company focuses on innovative TNF (Tumor Necrosis Factor)-based therapies. While early systemic TNF therapies showed high toxicity, later breakthroughs came from combining TNF with melphalan and IFN-gamma via isolated regional perfusion, yielding strong results in limb sarcomas and melanoma. Refnot-Pharm continues to advance research on cytokines for targeted cancer treatment.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Russia
Address
Address
123557, Moscow,Presnenskiy val, 17
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty